Here are relevant reports on : regenerative-medicine-market
-
Digital Twins in Healthcare Market by Component (Software, Services), Application (Personalized Medicine, Drug Discovery, Medical Education, Workflow Optimization), End User (Providers, Research & Academia, Payers), and Region - Global Forecast to 2030
The global digital twins in healthcare market, valued at US$2.69B in 2024, is forecasted to grow at a 68.0% CAGR, reaching US$4.47B by 2025 and US$59.94B by 2030. AI and machine learning algorithms can help analyze and interpret large volumes of data, identify trends, and forecast outcomes, particularly as data from sources like healthcare providers and payers become more accessible.
- Published: May 2025
- Price: $ 4950
- TOC Available:
-
Poultry Medicine/Pharmaceuticals Market by Animal Type (Chickens, Turkeys, Ducks), Product (Drugs, Vaccines, Feed Additives), Disease Indication (Newcastle disease, Infectious Bursal Disease, Salmonella), Route of Administration - Global Forecast to 2029
The global poultry medicine/pharmaceuticals market, valued at US$4.73 billion in 2023, stood at US$5.01 billion in 2024 and is projected to advance at a resilient CAGR of 5.9% from 2024 to 2029, culminating in a forecasted valuation of US$6.68 billion by the end of the period. The growth of the poultry medicine/pharmaceutical industry can be attributed to the rising global population and consumption of poultry meat and eggs leading to more poultry farming practiced notably in the developing regions where poultry is the cheapest source of protein.
- Published: January 2025
- Price: $ 4950
- TOC Available:
-
Airway Management Devices Market by Type (Endotracheal tubes, Tracheostomy tube, Oropharyngeal, Nasopharyngeal, Laryngoscopes, Resuscitators), Application (Anesthesia, Emergency medicine), End User (Hospitals, Home care settings) - Global Forecast to 2028
The global airway management devices market, valued at US$1.8 billion in 2022, stood at US$1.9 billion in 2023 and is projected to advance at a resilient CAGR of 5.6% from 2023 to 2028, culminating in a forecasted valuation of US$2.4 billion by the end of the period. The growth in this market is attributed to the increasing demand for airway management devices in developing countries, the rise in surgical procedures, and the growing prevalence of chronic respiratory diseases such as asthma and COPD.
- Published: April 2023
- Price: $ 4950
- TOC Available:
-
Hybrid System Market by System (Start-Stop, Regenerative Braking, EV Drive, eBoost), Component (Battery, DC/DC Converter, DC/AC Inverter, eMotor), Battery (Li-Ion, Lead Acid, NiMH), Vehicle (Mild Hybrid, HEV, PHEV, EV) - Global Forecast to 2022
The hybrid system market is projected to grow at a CAGR of 10.79% during the forecast period and is projected to reach USD 40.99 billion by 2022. Owing to the benefits offered by hybrid system, such as elimination of mechanical linkages, improved fuel efficiency and, thereby, decreased tail-pipe emissions, the demand for these systems is projected to grow in near future. Also, secondary factors such as increase in demand for electric & hybrid vehicles, government subsidies for BEVs, and investments in charging infrastructure will fuel the demand for hybrid systems in the coming years. The hybrid system market is dominated by a few global players. Some of the key manufacturers operating in the market are Bosch (Germany), Continental (Germany), Denso (Japan), ZF (Germany), and Valeo (France). There are certain key innovators gaining attention in the hybrid system market including UQM Technologies (US), Schaeffler (Germany), and Johnson Controls (US).
- Published: October 2017
- Price: $ 4950
- TOC Available:
-
Industrial Burner Market by Type (Regenerative, High Thermal, Radiant, Direct-Fired), Fuel Type (Oil, Gas, Dual, Solid), End Use (F&B, Petrochemical, Power, Chemical, Metals & Mining), Operating Temperature, Automation, Region - Global Forecast to 2027
The industrial burner market is expected to grow from USD 5.9 billion in 2022 to USD 7.9 billion in 2027, at a CAGR of 6.1% during the forecast period. To enable an in-depth understanding of the competitive landscape, the report includes the profiles of some of the top players in the industrial burner market. These include including ANDRITZ Group (Austria), NIBE Group (Sweden), Honeywell International Inc. (US), Ariston Group N.V. (Italy), Fives (France), and Riello S. p. A. (Italy). The leading players are trying to establish themselves in the markets of developed countries and are adopting various strategies to increase their respective market shares.
- Published: May 2022
- Price: $ 4950
- TOC Available:
-
Automotive Energy Recovery Systems Market by Regenerative Braking [by Region (Asia-Oceania; North America; Europe; and ROW) & by Passenger Car Type (Electric Vehicles, Hybrid Vehicles, and Plug-in Hybrid Electric Vehicles)], by Waste Heat Recovery Systems (by EGR and by Turbochargers), by KERS [by Region (Asia-Pacific, Europe, North America, and ROW)] - Global Trends and forecast to 2019
Automotive energy recovery systems market size, in terms of volume, is projected to grow at a promising CAGR of 9.03% to reach 139.4 Million units by 2019. The market is dominated by players such as Continental AG (Germany), Robert Bosch GmbH (Germany), and Denso Corporation (Japan).
- Published: September 2014
- Price: $ 4950
- TOC Available:
-
Blower Market by Product Type (Positive Displacement , Centrifugal , High-speed Turbo , Regenerative ), Pressure (Up to 15 PSI,15-20 PSI, Above 20 PSI), Distribution Channel, End-user Industry and Region - Global Forecast to 2028
The global blower market is projected to reach USD 4.6 billion by 2028, at a CAGR of 4.8% during the forecast period. Some of the major players in the blower market are Atlas Copco (Sweden), Ingersoll Rand (US), Kaeser Kompressoren (Germany), Aerzen (Germany), and Xylem (US). The major strategies adopted by these players include sales contracts, product launches, investments, collaborations, partnerships, and expansions.
- Published: December 2023
- Price: $ 4950
- TOC Available:
-
Nucleic Acid Isolation and Purification Kits Market by Type (DNA, RNA, Total Nucleic Acid, Others), Method (Column, Magnetic Beads, Reagent), Application (Diagnostics, Personalized Medicine), End User (Pharma & Biotech, CROs) – Global Forecast to 2030
The nucleic acid isolation and purification kits market is projected to reach USD 4.82 billion by 2030 from USD 3.02 billion in 2025, at a CAGR of 9.8% during the forecast period. Key companies active in the nucleic acid isolation and purification kits market include Thermo Fisher Scientific (US), QIAGEN (Germany), F. Hoffman-La Roche (Switzerland), Agilent Technologies, Inc. (US), and Takara Bio Inc. (Japan), along with other regional and global companies.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
North American Nuclear Medicine Market / Radiopharmaceuticals Market Size by Type (Diagnostic (SPECT - Technetium, PET- F-18), Therapeutic (Beta Emitters – I-131, Alpha Emitters, Brachytherapy – Y-90)), Application (Oncology, Cardiology) & Region - Global Forecast to 2024
North american nuclear medicine market growth is primed to transition from $2.2 billion in 2019 to $2.7 billion by 2024, showcasing a strong CAGR of 4.1%. Growth in the market can primarily be attributed to factors such as the increasing incidence and prevalence of cancer & cardiac ailments and initiatives to lessen the demand-supply gap of Mo-99. However, the short half-life of radiopharmaceuticals reduces their potential adoption, while hospital budget cuts and high equipment prices are expected to limit market growth to a certain extent.
- Published: January 2020
- Price: $ 4950
- TOC Available:
-
Nuclear Medicine Market by Type [SPECT (Tc-99m, I-123, Ga-67), PET (F-18), Alpha Emitters, Beta Emitters (Y-90, Lu-177), Brachytherapy], Application (Oncology, Cardiology, Neurology), Procedure, End User (Imaging Center, Hospital), and Region -Global Forecast to 2030
The global nuclear medicine market, valued at US$9.03 billion in 2024, stood at US$10.41 billion in 2025 and is projected to advance at a resilient CAGR of 15.1% from 2025 to 2030, culminating in a forecasted valuation of US$21.01 billion by the end of the period. The growth of the market is driven by the rising prevalence of cancer and cardiovascular diseases, which is accelerating the demand for diagnostic and therapeutic radiopharmaceuticals and medical radioisotopes.
- Published: January 2026
- Price: $ 4950
- TOC Available:
Records 41 to 50 of 50
